📚 ESC 2025 Coverage: Finding the Silent Beat: Remote ECG Screening Slightly Boosts Atrial Fibrillation Detection, by Dr. Tahmtan, Fellowship of Electrophysiology.

📚 ESC 2025 Coverage: Cholesterol Crushed, But Grafts Still Failed: Evolocumab Misses the Mark in NEWTON-CABG, by Dr. Ghavidel, Cardiovascular Surgeon.

📚 ESC 2025 Coverage: Cholesterol Crushed, But Grafts Still Failed: Evolocumab Misses the Mark in NEWTON-CABG, by Dr. Ghavidel, Cardiovascular Surgeon.

📚 ESC 2025 Coverage: More Isn’t Always Better: Dual Antiplatelet Therapy Falls Short After CABG for ACS, by Dr. Mehrpouya, Interventional Cardiologist.

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum

VICTORIA and VICTOR Clinical Trials

📚 ESC 2025 Coverage: Bridging Stability and Severity: Vericiguat’s Role Expands in Heart Failure Therapy, by Dr. Taghavi, Fellowship of Heart Failure.

Reduction of Antihypertensive Treatment in Nursing Home Residents

📚 ESC 2025 Coverage: Taking the Pressure Off, Gently: Can Fewer BP Pills Help Frail Elders Thrive? by Dr. Mansouri, Internal Medicine Specialist.

High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults

📚 ESC 2025 Coverage: Double the Dose, Double the Defense? by Dr. Soleimani, Cardiovascular Specialist.

Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction (TARGET-FIRST)

Apixaban for Extended Treatment of Provoked Venous Thromboembolism (HI-PRO)

Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF RCT

📚 Impact 52: Finerenone and mode of death in HF: Where do we stand? A review by Dr. Soltani Moghadam, Cardiovascular Researcher.